Soft tissue volume augmentation at single implant sites with a collagen based 3D matrix with oriented open pore structure: A retrospective analysis of 45 consecutive cases.

Soft tissue volume augmentation at single implant sites with a collagen based 3D matrix with oriented open pore structure: A retrospective analysis of 45 consecutive cases. - Mucomaix/Mucogain Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015213

Enrollment

Registered

2018-09-11

Start date

2018-08-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention and / or regeneration of resorbed ridge after tooth loss. K08.2

Interventions

Group 1: Implantation of a collagen matrix (mucomaix, Matricel GmbH, Herzogenrath, Germany) into the buccal connective tissue layer due to a mucosal flap in single implant placement. The following alr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Single implant placement with adjacent dentition. Immediate implant or later implant placement with simultaneoussoft tissue volume augmentation by mucosal collagen matrix.

Exclusion criteria

Exclusion criteria: Smoker> 10/Day. Intake of Bisphosphonates. Intake of monocyclic antibodies. Active periodontitis. Uncontrolled diabetes

Design outcomes

Primary

Measure	Time frame
Volume Gain/ Volume Preservation	—

Secondary

Measure	Time frame
- Evaluation of soft tissue healing - Assessment of implant success- and survival-rates - Evaluation of soft tissue parameters - Assessment of the safety of the collagen matrix - Assessment of the esthetic success	—

Countries

Germany

Contacts

Public ContactBastian Wessing

Praxisklinik der Zahnheilkunde am Luisenhospital

bastian.wessing@googlemail.com02414007277

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026